Janumet Class Action Lawsuit

Janumet Class Action Lawsuit

Update: FDA to Investigate Janumet / Rhabdomyolysis Link December 1, 2017 – The FDA is considering taking regulatory action over Janumet and other diabetres drugs in its class after finding an increased risk of rhabdomyolysis with the drugs, according to...

IVC Filter Class Action Lawsuit

IVC Filter Class Action Lawsuit

Update: Bard Ordered to Pay $3.6 Million in First IVC Filter Bellwether Trial April 4, 2018 – A federal jury in Arizona on Friday ordered C.R. Bard, Inc. to pay $3.6 million to a Georgia woman who suffered serious complications...

DePuy Hip Implant Class Action Lawsuit

DePuy Hip Implant Class Action Lawsuit

Update: J&J Ordered to Pay $1 Billion in DePuy Hip Bellwether Trial December 2, 2016 – A Texas jury has found Johnson & Johnson’s DePuy Orthopaedics unit liable for over $1.04 billion in a 6-plaintiff bellwether trial alleging injuries from...

Depakote Class Action Lawsuit

Depakote Class Action Lawsuit

Update: Depakote Settlement Talks in Progress; Federal Judge Stays Litigation January 31, 2018 – U.S. District Court Judge Michael Reagan has paused more than 250 lawsuits alleging that AbbVie’s anti-seizure medicine Depakote causes birth defects after both parties agreed to...

Cold Therapy Class Action Lawsuit

Cold Therapy Class Action Lawsuit

$12.5 Million Award in Cold Therapy Lawsuit In August 2012, a jury in California awarded a woman $12.5 million for her cold therapy lawsuit, including $5 million in compensation and $7.5 million in punitive damages against Dr. David Chao and...

Byetta Class Action Lawsuit

Byetta Class Action Lawsuit

What is Byetta? Byetta (exenatide) is a type-2 diabetes drug that comes in a pre-filled injection pen. Byetta was developed by Amylin Pharmaceuticals from the venomous saliva of the Gila monster, a large lizard found in the American Southwest. Byetta...

Actos Class Action Lawsuit

Actos Class Action Lawsuit

Update: FDA Confirms Actos Bladder Cancer Link December 15, 2016 – FDA has updated its review of Actos, confirming that use of the drug may increase the risk of bladder cancer. While Actos labels already contain a warning about the...